The Mass of the Pathway: Isotope Substitution, Proton Tunneling, and a Preregistered Test of Boundary-Conditioned Mutation
The Mass of the Pathway: Isotope Substitution, Proton Tunneling, and a Preregistered Test of Boundary-Conditioned Mutation
Author: John Swygert
Publication date: August 3, 2026
Project: The Swygert Theory Of Everything AO
Document type: TSTOEAO hypothesis, methodological critique, and staged experimental protocol
Status: Proposed research program; no claim that proton tunneling has been established as a dominant source of spontaneous mutation
---
Authorship-Process Declaration
This paper originated in John Swygert’s recognition that isotope substitution offers an unusually direct way to alter a pathway parameter without merely adding or removing bulk energy.
The central originating proposition is:
> Changing the mass of the transferring nucleus changes the pathway weight before the molecular event occurs.
The supplied transcript describes a hypothesis in which proton transfer within DNA base pairs may contribute to tautomeric states and mutation. It then proposes replacing hydrogen with deuterium to reduce tunneling and alter mutation frequency.
That proposal contains a valuable experimental structure but also a major confounding problem: broad deuteration changes many biochemical processes besides the target proton-transfer pathway.
This paper converts the broad idea into a staged, controlled research program.
ChatGPT assisted with isotope-effect formalization, causal-chain design, confound analysis, preregistration, and drafting. John Swygert supplied the originating pathway interpretation and retains final authorship and adopting authority.
---
Evidence-Status Declaration
Conventional knowledge
Hydrogen and deuterium differ in nuclear mass.
Isotope substitution changes:
vibrational frequencies;
zero-point energies;
bond dynamics;
proton-transfer rates;
solvent properties;
and some reaction equilibria.
Proton transfer and tautomerization have long been proposed as possible contributors to rare DNA mispairing events.
Scientific uncertainty
The quantitative contribution of proton tunneling to spontaneous mutation in living cells remains unresolved.
Mutation also arises through:
replication errors;
spontaneous deamination;
oxidation;
alkylation;
strand damage;
repair failure;
polymerase infidelity;
mobile elements;
and other processes.
Heavy water changes cell growth, enzyme function, membrane behavior, metabolism, replication, and repair.
Therefore:
> A lower mutation rate in deuterated conditions would not, by itself, prove proton tunneling in DNA.
TSTOEAO interpretation
Nuclear mass is treated as a typed pathway parameter that alters the boundary action and therefore the weight of proton-transfer routes.
---
Abstract
Rare proton-transfer events within DNA base pairs have been proposed as one possible source of transient tautomeric states capable of altering base-pairing preferences.
Quantum tunneling provides a mass-sensitive transfer mechanism.
For a simplified barrier:
\[
T
\approx
\exp
\left[
-\frac{2a}{\hbar}
\sqrt{
2m(V_0-E)
}
\right].
\]
Replacing hydrogen with deuterium increases the nuclear mass \(m\) and generally reduces the tunneling factor under otherwise comparable conditions.
The simplest hypothesis is:
\[
w_{\mathrm{PT}}(H)
>
w_{\mathrm{PT}}(D),
\]
where \(w_{\mathrm{PT}}\) is the proton-transfer pathway weight.
A biologically stronger hypothesis is:
\[
\mu_H^{\mathrm{target}}
>
\mu_D^{\mathrm{target}},
\]
where \(\mu^{\mathrm{target}}\) is a specifically defined mutation class causally linked to the proposed transfer pathway.
The paper argues that whole-cell comparison in normal water and heavy water is insufficient as a decisive test because deuteration affects many pathways simultaneously.
A defensible program must proceed through four stages:
1. direct molecular characterization of isotope-sensitive proton transfer;
2. measurement of tautomer populations and lifetimes;
3. polymerase misincorporation assays under site-specific isotopic control;
4. cellular mutation-spectrum testing with strong repair, growth, metabolic, and toxicity controls.
The formal sequence is:
\[
E_n
\overset{\mathcal P}{\longrightarrow}
Q_n
\overset{\mathcal B_{b_n,m}}{\longrightarrow}
X_n
\overset{M_T}{\longrightarrow}
V_{T,n}
\overset{M_P}{\longrightarrow}
V_{P,n}
\overset{M_G}{\longrightarrow}
V_{G,n},
\]
where the receivers register tautomer state, polymerase outcome, and genomic mutation.
The central claim is:
> Mass does not merely change the object traveling through a fixed pathway. It changes the weight of the pathway itself.
A successful experiment would require a preregistered quantitative chain from isotope substitution to transfer rate, tautomer occupancy, misincorporation probability, and a specific mutation spectrum.
---
Keywords
TSTOEAO; proton tunneling; DNA mutation; isotope substitution; deuterium; tautomerization; kinetic isotope effect; pathway weight; preregistration
---
1. Introduction
Mutation is not one phenomenon.
It is a family of physical and biological events.
A theory connecting proton tunneling to mutation must therefore identify:
which proton moves;
between which atomic sites;
through which barrier;
with what lifetime;
under which base-pair geometry;
during which stage of replication;
and which mutation class should result.
Without that chain, “mutation rate” is too broad a receiver.
---
2. The Transcript’s Proposal
The transcript describes protons within DNA base pairs moving to altered positions, potentially changing pairing behavior during copying. It then proposes comparing bacterial mutation under hydrogen-rich and deuterium-rich conditions because the heavier deuteron should tunnel less readily.
The structure is scientifically valuable:
\[
\text{mass change}
\rightarrow
\text{pathway change}
\rightarrow
\text{outcome-rate change}.
\]
The broad implementation requires refinement.
---
3. Tautomeric Base Pairing
DNA bases can exist in rare alternative protonation or tautomeric states.
A rare tautomer may present a different hydrogen-bond pattern.
If the altered state persists during polymerase selection, it may favor a noncanonical pairing.
The proposed causal chain is:
\[
\text{proton transfer}
\rightarrow
\text{rare tautomer}
\rightarrow
\text{mispair}
\rightarrow
\text{replication}
\rightarrow
\text{fixed mutation}.
\]
Each arrow must be independently measured or strongly modeled.
---
4. Tunneling Mass Dependence
For a one-dimensional approximation:
\[
T(m)
\approx
e^{-2a\sqrt{2m(V_0-E)}/\hbar}.
\]
Because:
\[
m_D\approx 2m_H,
\]
the leading tunneling exponent is larger for deuterium.
Thus:
\[
T_D<T_H
\]
under matched barriers and energies.
But isotope substitution also changes:
zero-point energy;
bond length distribution;
vibrational coupling;
solvent reorganization;
and equilibrium constants.
The experiment must distinguish tunneling-sensitive predictions from general isotope chemistry.
---
5. Preparation Map
The available molecular capacity is:
\[
E_n=
\left(
\text{base pair},
\text{solvent},
\text{temperature},
\text{polymerase resources},
\text{nucleotide pool}
\right).
\]
Preparation is:
\[
Q_n=
\mathcal P
\left(
E_n,
b_n^{\mathrm{prep}},
H_n
\right).
\]
The prepared state must specify:
base-pair identity;
sequence context;
protonation state;
hydration;
geometry;
and isotope placement.
Whole-cell solvent substitution is too coarse to define the target state adequately.
---
6. Route-State
The route set may include:
\[
R_n=
\left\{
r_{\mathrm{canonical}},
r_{\mathrm{PT}},
r_{\mathrm{return}},
r_{\mathrm{deam}},
r_{\mathrm{oxid}},
r_{\mathrm{repair}},
\dots
\right\}.
\]
The target pathway is:
\[
r_{\mathrm{PT}}
=
\text{proton-transfer-induced tautomerization}.
\]
Its route weight is:
\[
w_{\mathrm{PT}}
=
f
\left(
m,V(x),a,T,\chi,\epsilon,H_n
\right).
\]
Mutation requires additional routes after proton transfer.
A proton-transfer event that immediately reverses without affecting polymerase does not become a mutation.
---
7. Boundary-State Parameters
The target boundary is:
\[
b_n=
\left(
m,
V(x),
a,
T,
\epsilon,
\chi,
\mathbf E_{\mathrm{local}},
t_{\mathrm{rep}},
k_{\mathrm{return}}
\right).
\]
Here:
\(m\) is nuclear mass;
\(V(x)\) is the proton-transfer potential;
\(a\) is effective barrier width;
\(T\) is temperature;
\(\epsilon\) is dielectric environment;
\(\chi\) is base-pair conformation;
\(\mathbf E_{\mathrm{local}}\) is local electric field;
\(t_{\mathrm{rep}}\) is polymerase encounter timing;
and \(k_{\mathrm{return}}\) is the reverse-transfer rate.
Mutation probability depends not only upon transfer but also upon timing.
---
8. Multi-Receiver Architecture
8.1 Tautomer receiver
\[
V_T
=
M_T(X)
\]
measures:
tautomer population;
lifetime;
transfer rate;
and isotope dependence.
8.2 Polymerase receiver
\[
V_P
=
M_P(V_T)
\]
measures:
nucleotide insertion;
mismatch extension;
and error rate.
8.3 Genomic receiver
\[
V_G
=
M_G(V_P)
\]
measures:
fixed mutation;
mutation spectrum;
sequence context;
and strand dependence.
The final mutation rate is several causal levels removed from the proton-transfer event.
---
9. Why Heavy Water Alone Is Not Decisive
Replacing ordinary water with heavy water alters:
enzyme kinetics;
hydrogen-bond networks;
protein stability;
membrane behavior;
metabolic rate;
growth rate;
replication timing;
repair activity;
oxidative stress;
and cell survival.
Therefore:
\[
\mu_H\neq\mu_D
\]
does not uniquely imply:
\[
w_{\mathrm{PT}}(H)\neq w_{\mathrm{PT}}(D).
\]
The intervention is broad.
The causal target is narrow.
---
10. Preferred Intervention
The strongest design would use site-specific isotopic substitution or a highly controlled cell-free system.
Possible approaches include:
isotopically labeled base analogues;
synthetic oligonucleotides with defined exchangeable sites;
controlled hydration;
purified polymerase;
matched nucleotide pools;
and direct spectroscopic or kinetic measurement.
The objective is to change the mass of the transferring nucleus while minimizing changes elsewhere.
---
11. Stage One: Molecular Transfer
The first study should test:
\[
k_{\mathrm{PT},H}
>
k_{\mathrm{PT},D}.
\]
It should measure:
transfer rate;
reverse-transfer rate;
equilibrium population;
lifetime;
temperature dependence;
and barrier parameters.
The primary outcome should not yet be mutation.
It should be the transfer process itself.
---
12. Stage Two: Tautomer Population
The second study should test:
\[
P(T^\ast\mid H)
>
P(T^\ast\mid D),
\]
where \(T^\ast\) is the declared rare tautomeric state.
The receiver must distinguish:
tautomerization;
protonation;
base opening;
and other structural changes.
A total spectral shift without state assignment is insufficient.
---
13. Stage Three: Polymerase Error
The third study should use a purified replication system.
The prediction is:
\[
P
\left(
\text{specific misincorporation}
\mid H
\right)
>
P
\left(
\text{same misincorporation}
\mid D
\right).
\]
The mutation class must follow from the proposed altered pairing geometry.
A general increase or decrease in all errors would suggest broader enzyme or solvent effects.
---
14. Stage Four: Cellular Mutation Spectrum
Only after the molecular and polymerase chain is supported should a cellular test begin.
The primary outcome should be a mutation spectrum:
\[
\boldsymbol{\mu}
=
\left(
\mu_{A\to G},
\mu_{G\to A},
\mu_{C\to T},
\dots
\right).
\]
The theory must predict:
which substitutions change;
in which sequence contexts;
by how much;
and over what time.
Total mutation count is too nonspecific.
---
15. Required Controls
The cellular protocol must control:
growth rate;
generation count;
viability;
replication timing;
repair capacity;
polymerase expression;
oxidative stress;
metabolic state;
nucleotide-pool balance;
cell-cycle distribution;
and isotope incorporation.
Mutation counts must be normalized by actual replication opportunity, not only clock time.
---
16. Causal Chain
The proposed causal graph is:
\[
m
\rightarrow
w_{\mathrm{PT}}
\rightarrow
P(T^\ast)
\rightarrow
P(\mathrm{mispair})
\rightarrow
P(\mathrm{fixation})
\rightarrow
\mu_{\mathrm{target}}.
\]
Confounding pathways include:
\[
m
\rightarrow
\text{enzyme kinetics}
\rightarrow
\mu
\]
and:
\[
m
\rightarrow
\text{repair}
\rightarrow
\mu.
\]
The target claim requires mediation through the proton-transfer pathway, not merely a total isotope effect.
---
17. Boundary Equivalence
Two physical conditions may be designed to produce the same predicted tunneling action:
\[
\Lambda_H(b_a)
\approx
\Lambda_D(b_b).
\]
For example, a deuterium condition may use a narrower or lower barrier predicted to compensate for greater mass.
The boundary-equivalence prediction is:
\[
P(T^\ast\mid H,b_a)
\approx
P(T^\ast\mid D,b_b).
\]
This is stronger than merely predicting that deuterium lowers transfer.
It tests whether mass and barrier architecture combine through the proposed operative invariant.
---
18. EC-1 and EC-2
The program targets EC-1 through a preregistered isotope intervention producing a declared difference in a fixed receiver outcome.
It targets EC-2 by predicting a change in:
proton-transfer route weight;
tautomer channel;
polymerase-accessible mispairing;
and ultimately a specific mutation channel.
The Empirical Core prohibits calculating \(Y\) from the confirmatory value of \(V\) and requires the pathway and receiver to be declared in advance.
---
19. Distinctness
A finding that deuterium changes mutation rate is not automatically distinct.
Conventional isotope chemistry predicts broad effects.
TSTOEAO becomes distinct only if it prospectively predicts:
the correct molecular intermediate;
the correct mutation class;
the correct effect magnitude;
a boundary-equivalence condition;
and successful transfer across a new sequence or polymerase.
---
20. Failure Conditions
The model is weakened or locally falsified when:
direct proton-transfer isotope effects are absent beyond the registered margin;
the predicted tautomer does not change;
polymerase error changes in the wrong direction;
mutation-spectrum changes do not match the declared class;
broad growth or repair effects explain the result;
boundary equivalence fails;
or transfer fails.
---
21. Prohibited Rescue
After failure, investigators may not claim:
the proton tunneled but left no measurable consequence;
another unmeasured proton carried the effect;
the mutation occurred outside the declared sequence;
any isotope effect counts as support;
the substrate altered the repair system instead;
or the total mutation rate was the intended receiver all along.
The target pathway must remain fixed.
---
22. Governing Propositions
> Nuclear mass is a pathway parameter.
> Changing mass changes zero-point structure, vibrational dynamics, and potentially tunneling weight before transfer occurs.
> A mutation claim requires a measured causal chain from proton transfer to fixed genetic change.
> Heavy water is a broad intervention and cannot by itself uniquely identify the target pathway.
> The strongest test predicts a specific mutation spectrum, not merely a change in total mutations.
---
Conclusion
The hypothesis that proton transfer contributes to mutation is scientifically important because it connects a quantum-sensitive pathway to a durable biological record.
But the route from proton movement to mutation is long.
A proton must move.
The altered state must persist.
The polymerase must encounter it.
The wrong nucleotide must be inserted.
The mismatch must escape proofreading and repair.
The altered sequence must become fixed.
Only then does the pathway become committed genetic history.
The TSTOEAO architecture is:
\[
\text{nuclear mass}
\rightarrow
\text{boundary action}
\rightarrow
\text{proton-transfer weight}
\rightarrow
\text{tautomer population}
\rightarrow
\text{polymerase outcome}
\rightarrow
\text{mutation}.
\]
The mass does not merely characterize the particle.
It changes the route.
That is the central insight.
The transcript’s hydrogen-versus-deuterium experiment provides the right conceptual direction but not yet the right decisive design.
A whole-cell heavy-water comparison changes too many boundaries at once.
The scientifically stronger program begins at the molecular level, establishes the isotope-sensitive transfer, measures the tautomer, tests polymerase behavior, and only then moves into cells.
The most powerful version includes boundary equivalence.
A heavier particle under one barrier may be predicted to behave like a lighter particle under another if the operative action is equal:
\[
\Lambda_H(b_a)
\approx
\Lambda_D(b_b).
\]
If that equality predicts the same tautomer and error distribution before measurement, the model begins to demonstrate structure rather than merely correlation.
The governing sentence is:
> Change the mass, and the pathway changes before the biological result exists.
The proton comes before the tautomer.
The tautomer comes before the mispair.
The mispair comes before the mutation.
The mass of the pathway matters.
---
References
Godbeer, A. D., J. S. Al-Khalili, and P. D. Stevenson. “Modelling Proton Tunnelling in the Adenine–Thymine Base Pair.” Physical Chemistry Chemical Physics, 2015.
Kohen, Amnon, and Hans-Heinrich Limbach, editors. Isotope Effects in Chemistry and Biology. CRC Press, 2006.
Löwdin, Per-Olov. “Proton Tunneling in DNA and Its Biological Implications.” Reviews of Modern Physics, vol. 35, 1963.
Topal, M. D., and J. R. Fresco. “Complementary Base Pairing and the Origin of Substitution Mutations.” Nature, 1976.
Swygert, John. Boundary Equivalence: Different Physical Conditions, One Operative Encoded Equilibrium. The Swygert Theory Of Everything AO, 2026.
Swygert, John. The Barrier Is the Boundary: Quantum Tunneling, Enzyme Architecture, and the Pathway Before Chemical Transformation. The Swygert Theory Of Everything AO, 2026.
Swygert, John. TSTOEAO Empirical Core v1.0.0. 2026.
---
Comments
Post a Comment